This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Urokinase Antibody, NT fragment, clone 10D.7.2
catalog :
MAB7774
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, ELISA, other
citations: 1
Published Application/Species/Sample/Dilution | Reference |
---|---|
|
product information
Catalog Number :
MAB7774
Subcategory :
Metabolism
Product Name :
Anti-Urokinase Antibody, NT fragment, clone 10D.7.2
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P00749
Host Name :
Mouse
Antigen :
Urokinase
Clone :
10D.7.2
Conjugate :
Purified
Isotype :
IgG2a
Product Description :
Anti-Urokinase Antibody, NT fragment, clone 10D.7.2
Cross Reactivity :
Human
ALT Names :
uPA
Immunogen :
Amino Terminal Fragment of uPA
Specificity :
Urokinase Plasminogen Acitivator is a serine protease (SERPIN) that converts plasminogen into the active protease plasmin. uPA is secreted from cells in as the inactive 52 kDa single chain precursor which is activated into the two chain form consisting of an alpha and beta chain.MAB7774 is specific for Human uPA, other species not tested.
Package Size :
100 µg
Uses :
ELISA;Western Blotting
Storage :
Maintain refrigerated at 2-8°C in undiluted aliquots for up to 6 months.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments